This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08265/identifier/pdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08265/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08265/identifier/pubchem-substance/
n13http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08265/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08265/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08265
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB08265 n13:DB08265
dcterms:title
2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL
adms:identifier
n4:NDT n6:481709 n7:422598 n9:DB08265 n14:99444736
n5:IUPAC-Name
n8:271B475E-363D-11E5-9242-09173F13E4C5
n5:InChI
n8:271B4764-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n8:271B4763-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n8:271B4760-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n8:271B4761-363D-11E5-9242-09173F13E4C5
n5:SMILES
n8:271B4762-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n8:271B475C-363D-11E5-9242-09173F13E4C5
n5:logP
n8:271B475D-363D-11E5-9242-09173F13E4C5 n8:271B475A-363D-11E5-9242-09173F13E4C5
n5:logS
n8:271B475B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n8:271B476A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n8:271B476B-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n8:271B4765-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n8:271B4766-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n8:271B4768-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n8:271B4767-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n8:271B4769-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n8:271B4770-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n8:271B4772-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n8:271B4773-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n8:271B476F-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n8:271B476E-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n8:271B4771-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n8:271B475F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n8:271B476C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n8:271B476D-363D-11E5-9242-09173F13E4C5